| Product Code: ETC10223275 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sweden Prostate-Specific Antigen Blood-Based Biomarker Market Overview |
3.1 Sweden Country Macro Economic Indicators |
3.2 Sweden Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, 2021 & 2031F |
3.3 Sweden Prostate-Specific Antigen Blood-Based Biomarker Market - Industry Life Cycle |
3.4 Sweden Prostate-Specific Antigen Blood-Based Biomarker Market - Porter's Five Forces |
3.5 Sweden Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 Sweden Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Sweden Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume Share, By Test Sensitivity, 2021 & 2031F |
3.8 Sweden Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume Share, By End Use, 2021 & 2031F |
3.9 Sweden Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume Share, By Distribution, 2021 & 2031F |
4 Sweden Prostate-Specific Antigen Blood-Based Biomarker Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about prostate cancer screening |
4.2.2 Technological advancements in blood-based biomarker testing |
4.2.3 Growing prevalence of prostate cancer in Sweden |
4.3 Market Restraints |
4.3.1 Regulatory challenges in approving and commercializing blood-based biomarker tests |
4.3.2 High cost associated with biomarker testing |
4.3.3 Limited adoption of blood-based biomarker tests among healthcare providers |
5 Sweden Prostate-Specific Antigen Blood-Based Biomarker Market Trends |
6 Sweden Prostate-Specific Antigen Blood-Based Biomarker Market, By Types |
6.1 Sweden Prostate-Specific Antigen Blood-Based Biomarker Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Sweden Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Application, 2021 - 2031F |
6.1.3 Sweden Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Diagnostic Testing, 2021 - 2031F |
6.1.4 Sweden Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Screening, 2021 - 2031F |
6.1.5 Sweden Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Prognostic Testing, 2021 - 2031F |
6.1.6 Sweden Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Monitoring, 2021 - 2031F |
6.2 Sweden Prostate-Specific Antigen Blood-Based Biomarker Market, By Type |
6.2.1 Overview and Analysis |
6.2.2 Sweden Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Serum PSA, 2021 - 2031F |
6.2.3 Sweden Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Free PSA, 2021 - 2031F |
6.2.4 Sweden Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Total PSA, 2021 - 2031F |
6.2.5 Sweden Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Complex PSA, 2021 - 2031F |
6.3 Sweden Prostate-Specific Antigen Blood-Based Biomarker Market, By Test Sensitivity |
6.3.1 Overview and Analysis |
6.3.2 Sweden Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By High Sensitivity, 2021 - 2031F |
6.3.3 Sweden Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Low Sensitivity, 2021 - 2031F |
6.3.4 Sweden Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Specificity, 2021 - 2031F |
6.4 Sweden Prostate-Specific Antigen Blood-Based Biomarker Market, By End Use |
6.4.1 Overview and Analysis |
6.4.2 Sweden Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 Sweden Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.4.4 Sweden Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Diagnostic Centers, 2021 - 2031F |
6.5 Sweden Prostate-Specific Antigen Blood-Based Biomarker Market, By Distribution |
6.5.1 Overview and Analysis |
6.5.2 Sweden Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Direct-to-Consumer, 2021 - 2031F |
6.5.3 Sweden Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Pharmacies, 2021 - 2031F |
6.5.4 Sweden Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Hospitals, 2021 - 2031F |
7 Sweden Prostate-Specific Antigen Blood-Based Biomarker Market Import-Export Trade Statistics |
7.1 Sweden Prostate-Specific Antigen Blood-Based Biomarker Market Export to Major Countries |
7.2 Sweden Prostate-Specific Antigen Blood-Based Biomarker Market Imports from Major Countries |
8 Sweden Prostate-Specific Antigen Blood-Based Biomarker Market Key Performance Indicators |
8.1 Rate of adoption of blood-based biomarker testing in prostate cancer screening |
8.2 Number of research studies and publications supporting the efficacy of blood-based biomarker tests |
8.3 Level of government funding or support for prostate cancer screening programs |
9 Sweden Prostate-Specific Antigen Blood-Based Biomarker Market - Opportunity Assessment |
9.1 Sweden Prostate-Specific Antigen Blood-Based Biomarker Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 Sweden Prostate-Specific Antigen Blood-Based Biomarker Market Opportunity Assessment, By Type, 2021 & 2031F |
9.3 Sweden Prostate-Specific Antigen Blood-Based Biomarker Market Opportunity Assessment, By Test Sensitivity, 2021 & 2031F |
9.4 Sweden Prostate-Specific Antigen Blood-Based Biomarker Market Opportunity Assessment, By End Use, 2021 & 2031F |
9.5 Sweden Prostate-Specific Antigen Blood-Based Biomarker Market Opportunity Assessment, By Distribution, 2021 & 2031F |
10 Sweden Prostate-Specific Antigen Blood-Based Biomarker Market - Competitive Landscape |
10.1 Sweden Prostate-Specific Antigen Blood-Based Biomarker Market Revenue Share, By Companies, 2024 |
10.2 Sweden Prostate-Specific Antigen Blood-Based Biomarker Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here